Intrinsic Value of S&P & Nasdaq Contact Us

Evelo Biosciences, Inc. EVLO OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — EVLO

Evelo Biosciences, Inc. (EVLO) has a market capitalization of $1.9K and trades at $0.00. The 52-week range is 0.0001-0.002.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-26.28.

The stock has a beta of 0.62, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0001-0.002
Volume133
Avg Volume (30D)109
Market Cap$1.9K
Beta (1Y)0.62
Company
IPO Date2018-05-08
Employees66
CEOCraig R. Jalbert
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS2997342025
CUSIP299734103
Income (Latest Year)
EBITDA$-106.35M
Operating Income$-108.47M
Net Income$-114.53M
EPS$-26.28
EPS Diluted$-26.28
Shares Outstanding$4.36M
Balance Sheet (Latest Year)
Total Assets$64.44M
Current Assets$51.57M
Cash & ST Investments$47.94M
Total Liabilities$69.43M
Total Debt$51.14M
Net Debt$3.2M
Total Equity$-4.99M
Debt / Equity-10.24
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message